HomeNewsBusinessCompaniesRationalising R&D operations: Lupin scaling down drug discovery programme

Rationalising R&D operations: Lupin scaling down drug discovery programme

Pharma major Lupin has started to rationalise its R&D operations. The company has decided to scale down the drug discovery programme to focus on more near-term and mid-term opportunities. CNBC-TV18's Ekta Batra gave us more details.

September 12, 2017 / 20:44 IST
Story continues below Advertisement

Your browser doesn't support HTML5 video.

Pharma major Lupin has started to rationalise its R&D operations. The company has decided to scale down the drug discovery programme to focus on more near-term and mid-term opportunities. CNBC-TV18's Ekta Batra gave us more details.

Watch video for more…

Story continues below Advertisement
first published: Sep 12, 2017 08:33 pm

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!